http://www.ncbi.nlm.nih.gov/pubmed/22802290 Post navigationPreviousPrevious post:A progression-free end-point for idiopathic pulmonary fibrosis trials: lessons from cancer.NextNext post:Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms.